Ahluwalia MS - Search Results

1

NABTT 0502: a phase II and pharmacokinetic study of erlotinib and sorafenib for patients with progressive or recurrent glioblastoma multiforme.

Peereboom DM, Ahluwalia MS, Ye X, Supko JG, Hilderbrand SL, Phuphanich S, Nabors LB, Rosenfeld MR, Mikkelsen T, Grossman SA; New Approaches to Brain Tumor Therapy Consortium. Peereboom DM, et al. Among authors: ahluwalia ms. Neuro Oncol. 2013 Apr;15(4):490-6. doi: 10.1093/neuonc/nos322. Epub 2013 Jan 17. Neuro Oncol. 2013. PMID: 23328813 Free PMC article. Clinical Trial.

2

Pre-irradiation 9-amino [20s] camptothecin (9-AC) in patients with newly diagnosed glioblastoma multiforme.

Farray D, Ahluwalia MS, Snyder J, Barnett GH, Cohen BH, Suh JH, Peereboom DM. Farray D, et al. Among authors: ahluwalia ms. Invest New Drugs. 2006 May;24(3):177-80. doi: 10.1007/s10637-005-2464-5. Invest New Drugs. 2006. PMID: 16086097 Clinical Trial.

3

Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme.

Peereboom DM, Shepard DR, Ahluwalia MS, Brewer CJ, Agarwal N, Stevens GH, Suh JH, Toms SA, Vogelbaum MA, Weil RJ, Elson P, Barnett GH. Peereboom DM, et al. Among authors: ahluwalia ms. J Neurooncol. 2010 May;98(1):93-9. doi: 10.1007/s11060-009-0067-2. Epub 2009 Dec 4. J Neurooncol. 2010. PMID: 19960228 Clinical Trial.

4

Phase II trial of ritonavir/lopinavir in patients with progressive or recurrent high-grade gliomas.

Ahluwalia MS, Patton C, Stevens G, Tekautz T, Angelov L, Vogelbaum MA, Weil RJ, Chao S, Elson P, Suh JH, Barnett GH, Peereboom DM. Ahluwalia MS, et al. J Neurooncol. 2011 Apr;102(2):317-21. doi: 10.1007/s11060-010-0325-3. Epub 2010 Aug 4. J Neurooncol. 2011. PMID: 20683757 Clinical Trial.

5

Primary central nervous system lymphoma.

Ahluwalia MS, Peereboom DM. Ahluwalia MS, et al. Curr Treat Options Neurol. 2010 Jul;12(4):347-59. doi: 10.1007/s11940-010-0076-7. Curr Treat Options Neurol. 2010. PMID: 20842593

6

2010 Society for Neuro-Oncology Annual Meeting: a report of selected studies.

Ahluwalia MS. Ahluwalia MS. Expert Rev Anticancer Ther. 2011 Feb;11(2):161-3. doi: 10.1586/era.10.227. Expert Rev Anticancer Ther. 2011. PMID: 21342033

7

Flow cytometry as a diagnostic tool in lymphomatous or leukemic meningitis: ready for prime time?

Ahluwalia MS, Wallace PK, Peereboom DM. Ahluwalia MS, et al. Cancer. 2012 Apr 1;118(7):1747-53. doi: 10.1002/cncr.26335. Epub 2011 Oct 24. Cancer. 2012. PMID: 22025088 Free article. Review.

8

Role of tyrosine kinase inhibitors in the management of high-grade gliomas.

Ahluwalia MS, Patel M, Peereboom DM. Ahluwalia MS, et al. Expert Rev Anticancer Ther. 2011 Nov;11(11):1739-48. doi: 10.1586/era.11.166. Expert Rev Anticancer Ther. 2011. PMID: 22050023 Review.

9

Molecular targeted therapy in recurrent glioblastoma: current challenges and future directions.

Patel M, Vogelbaum MA, Barnett GH, Jalali R, Ahluwalia MS. Patel M, et al. Among authors: ahluwalia ms. Expert Opin Investig Drugs. 2012 Sep;21(9):1247-66. doi: 10.1517/13543784.2012.703177. Epub 2012 Jun 25. Expert Opin Investig Drugs. 2012. PMID: 22731981 Review.

10

The Cleveland Clinic experience with primary central nervous system lymphoma.

Xie H, Ahluwalia MS, Peereboom DM. Xie H, et al. Among authors: ahluwalia ms. Am J Clin Oncol. 2015 Apr;38(2):140-6. doi: 10.1097/COC.0b013e31828f5a26. Am J Clin Oncol. 2015. PMID: 23608829

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

261 results

Search Page

Filters